Tuesday, July 5, 2022

CRI OPENS NEW OVARIAN CANCER CLINICAL TRIAL

CRI OPENS NEW OVARIAN CANCER CLINICAL TRIAL

The first patients have been dosed in a new multi-center clinical trial testing new immunotherapy combinations in patients with an aggressive form of ovarian cancer that resists treatment with chemotherapy.


No comments:

Post a Comment